The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.


Updates from The Motley Fool

Latest updates on Eli Lilly and Co. from Fool.com.


Stock Performance

LLY vs. S&P 500 | 2 Year Performance
View Interactive LLY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Eli Lilly and Co..
Current Price: $78.24
Prev Close: $78.01
Open: $78.05
Bid: $77.50
Ask: $78.35
Day's Range: $77.84 - $78.82
52wk Range: $67.88 - $92.85
Volume: 2,602,317
Avg Vol 3,426,530
Market Cap: $86.70B
P/E (ttm): 33.48
EPS (ttm): $2.33
Div & Yield: $2.04 (2.6%)

Company Rating

What our community thinks about Eli Lilly and Co..
CAPS Rating 3 out of 5
 
1217 Outperform
105 Underperform
CAPS All Stars
 
339 Outperform
20 Underperform

How do you think Eli Lilly and Co. will perform against the market?



You pick for Eli Lilly and Co. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John C. Lechleiter, CEO

86% Approve

Based on 510 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Eli Lilly and Co..

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers